Clinical practice guidelines for the surgical treatment of rectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27064746)

Published in Ann Gastroenterol on April 12, 2016

Authors

Evaghelos Xynos1, Paris Tekkis2, Nikolaos Gouvas3, Louiza Vini4, Evangelia Chrysou5, Maria Tzardi6, Vassilis Vassiliou7, Ioannis Boukovinas8, Christos Agalianos9, Nikolaos Androulakis10, Athanasios Athanasiadis11, Christos Christodoulou12, Christos Dervenis13, Christos Emmanouilidis14, Panagiotis Georgiou2, Ourania Katopodi15, Panteleimon Kountourakis16, Thomas Makatsoris17, Pavlos Papakostas18, Demetris Papamichael16, George Pechlivanides9, Georgios Pentheroudakis19, Ioannis Pilpilidis20, Joseph Sgouros21, Charina Triantopoulou22, Spyridon Xynogalos23, Niki Karachaliou24, Nikolaos Ziras25, Odysseas Zoras26, John Souglakos27, [the Executive Team on behalf of the Hellenic Society of Medical Oncologists (HeSMO)]

Author Affiliations

1: General Surgery, InterClinic Hospital of Heraklion, Greece (Evangelos Xynos).
2: Colorectal Surgery, Chelsea and Westminster NHS Foundation Trust, London, UK (Paris Tekkis, Panagiotis Georgiou).
3: General Surgery, Metropolitan Hospital of Piraeus, Greece (Nikolaos Gouvas).
4: Radiation Oncology, Iatriko Center of Athens, Greece (Louza Vini).
5: Radiology, University Hospital of Heraklion, Greece (Evangelia Chrysou).
6: Pathology, University Hospital of Heraklion, Greece (Maria Tzardi).
7: Radiation Oncology, Oncology Center of Bank of Cyprus, Nicosia, Cyprus (Vassilis Vassiliou).
8: Medical Oncology, Bioclinic of Thessaloniki, Greece (Ioannis Boukovinas).
9: General Surgery, Athens Naval & Veterans Hospital, Greece (Christos Agalianos, George Pechlivanides).
10: Medical Oncology, Venizeleion Hospital of Heraklion, Greece (Nikolaos Androulakis).
11: Medical Oncology, Koutlibaneion Hospital of Larissa, Greece (Athanasios Athanasiadis).
12: Medical Oncology, Metropolitan Hospital of Piraeus, Greece (Christos Christodoulou).
13: General Surgery, Konstantopouleio Hospital of Athens, Greece (Christos Dervenis).
14: Medical Oncology, Interbalkan Medical Center, Thessaloniki, Greece (Christos Emmanouilidis).
15: Medical Oncology, Iaso General Hospital, Athens, Greece (Ourania Katopodi).
16: Medical Oncology, Oncology Center of Bank of Cyprus, Nicosia, Cyprus (Panteleimon Kountourakis, Demetris Papamichael).
17: Medical Oncology, University Hospital of Patras, Greece (Thomas Makatsoris).
18: Medical Oncology, Ippokrateion Hospital of Athens, Greece (Pavlos Papakostas).
19: Medical Oncology, University Hospital of Ioannina, Greece (Georgios Pentheroudakis).
20: Gastroenterology, Theageneion Cancer Hospital, Thessaloniki, Greece (Ioannis Pilpilidis).
21: Medical Oncology, Agioi Anargyroi Hospital of Athens, Greece (Joseph Sgouros).
22: Radiology, Konstantopouleio Hospital of Athens, Greece (Charina Triantopoulou).
23: Medical Oncology, George Gennimatas General Hospital, Athens, Greece (Spyridon Xynogalos).
24: Medical Oncology, Dexeus University Institute, Barcelona, Spain (Niki Karachaliou).
25: Medical Oncology, Metaxas Cancer Hospital, Piraeus, Greece (Nikolaos Ziras).
26: General Surgery, University Hospital of Heraklion, Greece (Odysseas Zoras).
27: Medical Oncology, University Hospital of Heraklion, Greece (John Souglakos).

Articles cited by this

(truncated to the top 100)

Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med (2004) 25.68

Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet (2005) 14.64

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med (2001) 13.75

Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med (2006) 12.50

Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet (2008) 9.92

The mesorectum in rectal cancer surgery--the clue to pelvic recurrence? Br J Surg (1982) 8.69

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol (2007) 8.05

Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group. J Clin Oncol (2007) 7.75

Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet (2001) 6.38

Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol (2005) 6.00

Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis (1997) 5.81

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med (2000) 5.68

Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol (2012) 5.41

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol (2011) 5.39

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Ann Oncol (2012) 5.32

Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet (2009) 4.58

Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol (2002) 4.02

Meta-analysis of defunctioning stomas in low anterior resection for rectal cancer. Br J Surg (2009) 3.57

Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging--a meta-analysis. Radiology (2004) 3.55

Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg (2004) 3.50

Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet (2009) 3.49

NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw (2009) 3.37

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol (2006) 3.24

Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg (2011) 3.12

Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol (2002) 3.09

Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol (2005) 2.91

Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg (2002) 2.89

Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA (2000) 2.76

Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol (2009) 2.68

Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg (2012) 2.55

Outcome of extralevator abdominoperineal excision compared with standard surgery: results from a single centre. Colorectal Dis (2012) 2.54

Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg (2007) 2.47

Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys (2003) 2.38

Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet (2002) 2.38

Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum (2003) 2.34

Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys (2008) 2.30

Laparoscopic versus open surgery for rectal cancer: a meta-analysis. Ann Surg Oncol (2006) 2.29

Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology (2007) 2.27

Optimal total mesorectal excision for rectal cancer is by dissection in front of Denonvilliers' fascia. Br J Surg (2004) 2.26

Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology (2003) 2.24

Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg (2010) 2.23

Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery. Ann Surg (2008) 2.22

The Swedish rectal cancer registry. Br J Surg (2007) 2.20

Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol (2007) 2.10

Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology (2010) 2.09

A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum (2003) 2.04

Colorectal carcinoma: diagnostic, prognostic, and molecular features. Mod Pathol (2003) 2.02

Extending the horizons of restorative rectal surgery: intersphincteric resection for low rectal cancer. Colorectal Dis (2007) 1.96

Workload and surgeon's specialty for outcome after colorectal cancer surgery. Cochrane Database Syst Rev (2012) 1.91

Risk factors and oncologic impact of anastomotic leakage after rectal cancer surgery. Dis Colon Rectum (2008) 1.86

Fast-track vs standard care in colorectal surgery: a meta-analysis update. Int J Colorectal Dis (2009) 1.82

Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev (2007) 1.80

Randomized clinical trial comparing laparoscopic and open surgery for colorectal cancer within an enhanced recovery programme. Br J Surg (2006) 1.75

Reporting colorectal cancer. Histopathology (2007) 1.68

Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg (2006) 1.68

MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer (2006) 1.68

Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg (2005) 1.64

International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams. World J Surg (2010) 1.62

Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer. Colorectal Dis (2008) 1.61

Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol (2010) 1.59

Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol (2004) 1.58

Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg (2000) 1.57

Anastomotic leak is not associated with oncologic outcome in patients undergoing low anterior resection for rectal cancer. Ann Surg (2012) 1.57

Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev (2006) 1.56

Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. J Clin Oncol (2011) 1.55

Preoperative staging of rectal cancer. Int J Colorectal Dis (2000) 1.52

Laparoscopic vs open resection for rectal cancer: a meta-analysis of randomized clinical trials. Colorectal Dis (2012) 1.49

Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol (2011) 1.49

Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol (2008) 1.46

Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol (2013) 1.34

Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol (2007) 1.31

Perineal repair after extralevator abdominoperineal excision for low rectal cancer. Dis Colon Rectum (2011) 1.31

Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94. Colorectal Dis (2003) 1.30

A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol (2006) 1.26

The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer (2009) 1.24

A systematic approach to the interpretation of preoperative staging MRI for rectal cancer. AJR Am J Roentgenol (2008) 1.22

Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum (2009) 1.20

Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis. Ann Surg Oncol (2012) 1.20

Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol (2010) 1.19

Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol (2008) 1.18

Nonoperative approaches to rectal cancer: a critical evaluation. Semin Radiat Oncol (2011) 1.17

Accurate prediction of pathological rectal tumor response after two weeks of preoperative radiochemotherapy using (18)F-fluorodeoxyglucose-positron emission tomography-computed tomography imaging. Int J Radiat Oncol Biol Phys (2009) 1.15

Long-term results of intersphincteric resection for low rectal cancer. Dis Colon Rectum (2009) 1.15

Loop ileostomy versus loop colostomy for fecal diversion after colorectal or coloanal anastomosis: a meta-analysis. Int J Colorectal Dis (2009) 1.14

USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology (2008) 1.14

Comparison of outcomes after restorative proctocolectomy with or without defunctioning ileostomy. Arch Surg (2008) 1.13

Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix: a basis for checklists. Cancer Committee. Arch Pathol Lab Med (2000) 1.13

Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer. Eur J Nucl Med Mol Imaging (2006) 1.10

Local staging of rectal cancer with transrectal ultrasound and endorectal magnetic resonance imaging: comparison with histologic findings. Dis Colon Rectum (2000) 1.10

Value of ADC measurements for nodal staging after chemoradiation in locally advanced rectal cancer-a per lesion validation study. Eur Radiol (2010) 1.08

A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for rectal cancer. J Gastrointest Surg (2011) 1.07

Laparoscopic-assisted versus open surgery for rectal cancer: a meta-analysis of randomized controlled trials on oncologic adequacy of resection and long-term oncologic outcomes. Int J Colorectal Dis (2010) 1.06

A prospective case-control study of extralevator abdominoperineal excision (ELAPE) of the rectum versus conventional laparoscopic and open abdominoperineal excision: comparative analysis of short-term outcomes and quality of life. Tech Coloproctol (2012) 1.05

A comparison of published rates of resection margin involvement and intra-operative perforation between standard and 'cylindrical' abdominoperineal excision for low rectal cancer. Colorectal Dis (2013) 1.05

Laparoscopic approach in surgical treatment of rectal cancer. Br J Surg (2007) 1.04

Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study. Ann Surg (2013) 1.03

Current trends in staging rectal cancer. World J Gastroenterol (2011) 1.02

High tie versus low tie of the inferior mesenteric artery in colorectal cancer: a RCT is needed. Surg Oncol (2012) 1.01

Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol (2006) 1.01